Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2020-05-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators wish to evaluate the effect of thyroid hormones on brown adipose tissue in humans in an observational study on patients with thyrotoxicosis. In the investigators evaluation the investigators will use FDG-PET/CT, indirect calorimetry and fat biopsies in the acute phase of the disease and in the euthyroid phase after treatment.

It is the investigators hypothesis that high levels of circulating T3 might affect amount and function of brown adipose tissue.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Thyroid Hormones Effect on Brown Adipose Tissue

NCT01376648

Hyperthyroidism

UNKNOWN

Effect of Hypothyroidism on Brown Adipose Tissue

NCT02364102

Hypothyroidism

COMPLETED

Brown Adipose Tissue Activity and Thyroid Hormone

NCT02499471

Hypothyroidism Hyperthyroidism Obesity

COMPLETED NA

Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition

NCT02891668

Hypothyroidism

COMPLETED

The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure

NCT03064542

Hyperthyroidism

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

10 patients with thyreotoxicosis (T3 \> 3 nmol/L and suppressed TSH) will be investigated at diagnosis and after 3-6 months of euthyroidism induced by antithyroid treatment. The patients will all be over the age of 50 due to the radiation given by the scans (requested by the local Ethical Committee). All will be scanned for active BAT by the integrated FDG PET-CT before and after treatment.BAT is activated by means of crushed ice placed under the feet in individualized intervals during the scan procedure. Indirect calorimetry is done to determine the basal metabolic rate and subcutaneous fat biopsy to examine the effect on subcutaneous white fat and the possible "browning" effect.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperthyroidism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

T3 > 4 nmol/l

Acute hyperthyroidism with a T3 \> 4 nmol/l

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men and women with hyperthyroidism (T3 \> 3 nmol/l)
* \> 50 years old
* women must be postmenopausal

Exclusion Criteria

* thyrotoxic crises
* severe concurrent sickness that will make it unsafe to postpone treatment, this includes severe kidney disease (creatinin over 160)- and heart disease (NYHA group 3 and 4).
* diabetes
* former and current treatment with interleukin-2
* Patients who are already treated with β-blockers
* severe claustrophobia
* BMI \> 30 kg/m2

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No